Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A single arm observational study investigating the incidence of brain metastasis in patients with cancer recti and lung metastasis
In this study the investigators want to investigate the incidence of brain metastasis in a selected high-risk group of patients with metastatic colorectal cancer. Possible prognostic biological aspects will be investigated by translational analysis of biological samples. The study population consists of patients with metastatic rectal cancer and presence of lung metastasis. The patients will undergo a standard MRI scan of the brain including injection of intravenous contrast. If positive finding, images will be evaluated at the multidisciplinary tumor board for potential treatment options according to clinical practice. Standard follow-up program is followed, as per clinical practice. If the initial MRI scan of cerebrum detects brain metastasis this will be treated and followed as per clinical practice. Translational blood samples will be drawn at inclusion and at every imaging schedule up til 5 times
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of brain metastasis | Incidence of brain metastasis in a high risk selected group | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Number of brain metastases eligible for local treatment options | Number of brain metastases eligible for local treatment options | 2 years |
| Median two year overall survival | Median two year overall survival |
Not provided
Inclusion Criteria:
Primary rectal tumor location
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study population consists of patients with metastatic rectal cancer and presence of lung metastasis.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anders K Boysen, MD, PhD | Department of Oncology, Aarhus University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Oncology, Aarhus University Hospital | Aarhus N | 8200 | Denmark |
Not provided
| ID | Term |
|---|---|
| D012004 | Rectal Neoplasms |
| D001932 | Brain Neoplasms |
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 years last patient |
| Prognostic value of circulating DNA levels at baseline | 2 years last patient |
| Descriptive biological analysis of tumor tissue and circulating tumor DNA | 2 years last patient |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
| D016543 | Central Nervous System Neoplasms |
| D009423 | Nervous System Neoplasms |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |